Xpeer course: Health outcomes of drugs-gut microbiota interactions

Synopsis of the course

Explore the intricate relationship between antibiotics and the human microbiome in this CME course, updated with the latest evidence in the field. Providing you with a more practical approach, the course now includes a clinical case revealing the profound impact of antibiotic therapy on gut health, and how relevant the knowledge acquired in this course will be to your clinical practice.

Understand how dysbiosis, characterized by microbial imbalance, underpins various gastrointestinal and systemic disorders.

Updated with cutting-edge research, discover novel insights into antibiotic-associated dysbiosis and its far-reaching consequences on patient health. Equip yourself with evidence-based strategies to mitigate dysbiosis-related complications and optimize patient outcomes. Join us to navigate the evolving landscape of drug-microbiome interactions in clinical practice.

Who is professor Guarner ?

• Francisco Guarner, MD, PhD. has a degree in Medicine and Surgery and specialized in Digestive Diseases.
• He carries out his professional activity in the Digestive Pathology Service of the Universitari Vall d'Hebró Hospital.
• He has been a research fellow at the Liver United at Kings College Hospital in London and a research fellow in the Prostaglandin Research department of Welcome Research Laboratories.
• He is currently a member of the Centre of Network Biomedical Research of hepatic and digestive diseases as principal investigator of the inflammatory bowel diseases group and a member of the Board of Directors of the International Scientific Association for Probiotics and Prebiotics.
• He is also president of the Board of Directors of the Probiotics and Prebiotics Spanish Society, member of the Guidelines & Publications Committee of WGO-OMGE (World Gastroenterology Organization) and member of the Steering Committee of the International Human Microbiome Consortium (IHMC).

Conflict of Interest Disclosure: Francisco Guarner receives research funding from Abbvie, Takeda and AB-Biotics, and consulting fees from the Danone Institute, Sanofi, Biocodex, Actial, Menarini and Ordesa.

What is Xpeer?

Xpeer Medical Education is the first accredited medical education app in the market, with video microlearning engaging videos of just 5 minutes.

With a powerful algorithm to personalize the user experience and the contents as the most popular entertaining streaming platforms, it offers a brand new experience for the continuing education and professional development of the healthcare professionals.

Accredited by the European Union of Medical Specialists, it delivers high quality scientific medical education pieces. On Xpeer, you will find this curriculum on Microbiota and 500 hours of medical education in 2021 in your specialty, technologies and professional and personal skills.

Information on accreditation

The app Xpeer is accredited by the European Accreditation Council for Continuing Medical Education (EACCME) to provide official ECMEC credits recognized officially in 26 countries.

The credits for the users of the module will be 1 European CME credit (ECMEC®) for every hour (60 minutes of actual e-learning excluding introductions etc.) of use, provided that the users have completed a module and have passed the relevant assessment.